<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) of the gastrointestinal (GI) tract is the most common extranodal <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, accounting for approximately 40% of <z:hpo ids='HP_0000001'>all</z:hpo> extranodal NHLs </plain></SENT>
<SENT sid="1" pm="."><plain>Initial treatment of duodenal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> includes surgery, chemotherapy and radiotherapy, alone or in combination </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we present a case of stage I primary duodenal follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) showing a complete response after rituximab therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Rituximab alone can be an effective alternative treatment for duodenal FL </plain></SENT>
</text></document>